scispace - formally typeset
J

Jing Zhao

Researcher at Sun Yat-sen University

Publications -  5
Citations -  166

Jing Zhao is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Protein kinase B & Cancer. The author has an hindex of 5, co-authored 5 publications receiving 121 citations.

Papers
More filters
Journal ArticleDOI

Smartphone Application WeChat for Clinical Follow-up of Discharged Patients with Head and Neck Tumors: A Randomized Controlled Trial

TL;DR: The smartphone WeChat application was found to be a viable option for follow-up in discharged patients with head and neck tumors and was time- effective, cost-effective, and convenient in communication.
Journal ArticleDOI

MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma

TL;DR: Wong et al. as mentioned in this paper reported a novel regulatory pathway controlled by miR-744-3p, which enhanced expression of matrix metallopeptidase 9 (MMP-9) in laryngeal squamous cell carcinoma (LSCC) cells.
Journal ArticleDOI

miR-375 and miR-205 Regulate the Invasion and Migration of Laryngeal Squamous Cell Carcinoma Synergistically via AKT-Mediated EMT

TL;DR: Findings provided not only new information about the molecular mechanism of miRNAs regulating invasion and migration of LSCC, but also a theoretical principle for potential targeting therapy of laryngeal squamous carcinoma.
Journal ArticleDOI

Comparison of CT and MRI in Diagnosis of Laryngeal Carcinoma with Anterior Vocal Commissure Involvement

TL;DR: Combined utility of CT and MRI could help improve the accuracy of assessment of thyroid cartilage involvement and T staging of laryngeal carcinomas with AVC involvement.
Journal ArticleDOI

Functional significance of the long non-coding RNA RP11-169D4.1 as a metastasis suppressor in laryngeal squamous cell carcinoma by regulating CDH1.

TL;DR: The long non-coding RNA RP11-169D4.1 may serve as a tumor suppressor and a promising therapeutic target in laryngeal cancer, which could inhibit the process of EMT by regulating CDH1.